LXEO position history
The shares of Lexeo Therapeutics (LXEO) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q3: 250,583 shares, $2.3M, 0.54% of portfolio, New
- 2024 Q4: 393,083 shares, $2.6M, 0.66% of portfolio, Add +56.9%
- 2025 Q1: 378,083 shares, $1.3M, 0.37% of portfolio, Reduce −3.8%
- 2025 Q2: 378,083 shares, $1.5M, 0.42% of portfolio
- 2025 Q3: 358,083 shares, $2.4M, 0.59% of portfolio, Reduce −5.3%
- 2025 Q4: 340,859 shares, $3.4M, 0.79% of portfolio, Reduce −4.8%
- 2026 Q1: 377,059 shares, $2.2M, 0.49% of portfolio, Add +10.6%
- 2026 Q2: 377,059 shares, $1.8M, 0.33% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|